{
  "docId": "019dd923-5fed-74f2-a970-22e81ff63ce8",
  "docSlug": "bi-afad71c64ca4f4b7",
  "documentTitle": "Meliora Therapeutics pitch deck: $11 million seed round",
  "authorId": "Pitchdecks",
  "authorName": "Meliora Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 2,
  "pageCount": 14,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "overcrowded",
  "nDataPoints": 9,
  "notes": "Uses a bar chart to contrast oncology success rates with other medical fields and includes external validation from NYT and Science Translational Medicine.",
  "elementsJson": [
    "action_title",
    "bar_chart_horizontal",
    "callout_box",
    "photo",
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fed-74f2-a970-22e81ff63ce8/2",
  "deckHref": "/decks/019dd923-5fed-74f2-a970-22e81ff63ce8",
  "deckJsonHref": "/decks/019dd923-5fed-74f2-a970-22e81ff63ce8.json",
  "deckAnchorHref": "/decks/019dd923-5fed-74f2-a970-22e81ff63ce8#slide-2",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Drugs often fail in the clinic due to a critical lack of understanding of the true molecular mechanism underlying a drug's effects",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-c5b0-71fc-abf9-6ab4b7ca4a61",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.45,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "chart",
      "text": "PROBABILITY OF SUCCESS FOR CLINICAL STAGE ASSETS",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0493921e-a49f-44d3-9c60-43c06d611915",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.18,
        "x": 0.58,
        "y": 0.0046
      },
      "kind": "image",
      "text": "Science Translational Medicine cover art showing a target with missed arrows",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "333894d4-89de-4402-b6df-ba9e5a1da0fa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.64,
        "y": 0.00125
      },
      "kind": "image",
      "text": "The New York Times: Why Aren't Cancer Drugs Better? The Targets Might Be Wrong",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "16d61fe9-21e2-465f-a8d1-144f4dff244c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Probability of success: 3%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-c5b0-71fc-abf9-734323790df7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.18,
        "x": 0.79,
        "y": 0.005900000000000001
      },
      "kind": "paragraph",
      "text": "Drugs often fail in the clinic due to a critical lack of understanding of the true molecular mechanism underlying a drug's effects",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6ca1d3b-2e1f-4f7c-a10a-44fa9716fa73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Why Aren't Cancer Drugs Better? The Targets Might Be Wrong - The New York Times",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-c5b0-71fc-abf9-6cfb565f961f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.13,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "Source: Wong et al. 2019",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b460f9fe-f736-42ba-9934-0e7a67864637",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.05,
        "y": 0.13
      },
      "kind": "title",
      "text": "97% OF ONCOLOGY THERAPEUTICS ARE FAILING IN THE CLINIC, THE HIGHEST OF ANY INDICATION",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6699dc5-f1c2-4271-948c-c5f9b3f2f436",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "c05beee2-abd8-471e-9d06-65a45f763a7d",
      "evidence": "chart/bar-horizontal: PROBABILITY OF SUCCESS FOR CLINICAL STAGE ASSETS",
      "confidence": 0.5
    },
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "d96e5d6e-a8c0-41f2-8c84-2fc9e5ae7430",
      "evidence": "paragraph/paragraph: Drugs often fail in the clinic due to a critical lack of understanding of the true molecular mechanism underlying a drug's effects",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "2ff626f2-e4f3-4087-a9fe-5339a8ae4d1a",
      "evidence": "Citing NYT and Science Translational Medicine to validate the problem statement.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 2,
      "from": 2,
      "beatId": "28bafa9b-f2bc-4f4c-a767-6f3460612c08",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "High failure rate of oncology therapeutics",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 2,
      "from": 2,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "55d8ec9e-c42f-4e05-ac49-004a1da4dca8",
      "evidence": "High failure rate of oncology therapeutics",
      "position": 0,
      "objective": "What is the cost of not improving oncology drug development?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}